Access-site hematoma in distal and conventional transradial access: a randomized trial

医学 经皮冠状动脉介入治疗 心肌梗塞 血肿 随机对照试验 心脏病学 内科学 外科
作者
Stefano Lucreziotti,Simone Persampieri,Domitilla Gentile,Lucia Barbieri,Diego Salerno‐Uriarte,F Valli,Ludovico Sabatelli,G Panzacchi,Marco Centola,Stefano Carugo
出处
期刊:Minerva cardiology and angiology [Edizioni Minerva Medica]
卷期号:70 (2) 被引量:8
标识
DOI:10.23736/s2724-5683.21.05483-9
摘要

BACKGROUND: Distal transradial access (dTRA) has been recently proposed as an innovative access for coronary procedures and a valuable alternative to conventional transradial access (cTRA). The aim of this study was to assess the safety of dTRA versus cTRA in patients undergoing percutaneous coronary angiography and intervention.METHODS: In this single-center randomized trial, consecutive patients admitted for stable cardiac condition or acute coronary syndrome (ACS) were assigned to dTRA or cTRA. The primary endpoint was an early discharge after transradial stenting of coronary arteries (EASY) grade ≥II access-site hematoma (ASH). Vascular access failure, radial artery occlusion (RAO) at hospital discharge, 30-day rates of death, myocardial infarction, stroke and bleeding not related to coronary artery bypass grafting were considered as secondary endpoints.RESULTS: A total of 204 patients were included and randomized to dTRA (N.=100) or cTRA (N.=104). The two populations were similar, except for a higher percentage of ACS in the dTRA than in the cTRA group (38% versus 24%, P=0.022). The rate of EASY grade ≥II ASH was lower in dTRA than in cTRA patients, but the difference was not statistically significant (4% versus 8.4%, respectively, P=0.25). Vascular access failure was more frequent in dTRA patients than in cTRA patients (34% versus 8.7%, P<0.0001). We detected no case of RAO at hospital discharge and similar rates of 30-day adverse events in both groups.CONCLUSIONS: DTRA is safe and feasible. When compared to cTRA, dTRA is technically more demanding and limited by more frequent crossover to an alternative vascular access.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様的应助被369ninja采纳,获得10
1秒前
1秒前
hhhh完成签到,获得积分10
1秒前
guohezu发布了新的文献求助10
1秒前
yangsw1991完成签到,获得积分10
2秒前
2秒前
晫猗完成签到,获得积分10
3秒前
妙奇完成签到,获得积分10
3秒前
明珠完成签到,获得积分10
3秒前
NexusExplorer的应助被lan采纳,获得10
3秒前
3秒前
Earl完成签到,获得积分10
4秒前
xuan完成签到,获得积分10
4秒前
Foster完成签到,获得积分10
4秒前
good1luck2完成签到,获得积分10
4秒前
5秒前
孙朱珠发布了新的文献求助10
5秒前
rita完成签到,获得积分10
5秒前
ku芮完成签到,获得积分10
5秒前
FashionBoy的应助被最好的采纳,获得10
5秒前
飞快的涵柳完成签到,获得积分10
6秒前
热心起眸完成签到,获得积分10
6秒前
6秒前
书写笔迹发布了新的文献求助10
6秒前
高山我梦发布了新的文献求助10
7秒前
didi完成签到,获得积分10
7秒前
打打的应助被顺利的莺采纳,获得50
7秒前
嗡嗡嗡嗡嗡嗡完成签到,获得积分10
8秒前
科目三的应助被小熊维尼采纳,获得10
8秒前
9秒前
10秒前
orange发布了新的文献求助10
10秒前
fight完成签到,获得积分10
10秒前
小小发布了新的文献求助50
10秒前
深情雨泽发布了新的文献求助10
10秒前
青年晚报完成签到,获得积分10
11秒前
灵巧雪枫完成签到,获得积分10
11秒前
11秒前
fsy完成签到 ,获得积分10
11秒前
兴奋冰绿完成签到 ,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180189
求助须知:如何正确求助?哪些是违规求助? 9570320
关于积分的说明 21810161
捐赠科研通 7776320
什么是DOI,文献DOI怎么找? 3433267
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479039